Dexamethasone for ESPB in Total Hip Arthroplasty

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-02-01

Study Completion Date

2025-07-18

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Effect of adding Dexamethasone to Erector Spinae Plane Block in Patients undergoing Total Hip Arthroplasty

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Dexamethasone for PENG Block in Total Hip Arthroplasty

NCT06470139

Hip Osteoarthritis Hip Arthropathy Hip Pain Chronic

COMPLETED PHASE4

Dexamethasone With Ropivacaine for PENG Block in Total Hip Arthroplasty

NCT06470334

Hip Osteoarthritis Hip Pain Chronic Hip Arthritis

COMPLETED PHASE4

The Effect of Dexamethasone Administration Route on Pain and Inflammatory Response in PENG Block for Total Hip Arthroplasty

NCT06789328

Osteoarthritis, Hip Hip Pain Chronic Hip Arthropathy +1 more

COMPLETED PHASE4

PENG Block Optimization: Volume and Dexamethasone Effects

NCT07023120

Hip Arthropathy Hip Osteoarthritis Hip Arthritis

RECRUITING PHASE4

The Efficacy of Suprainguinal Fascia Iliaca Compartment Block for Analgesia After Elective Total Hip Replacement.

NCT04690647

Anesthesia, Local Analgesia Arthropathy of Hip

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Hip arthroplasty is one of the most common orthopaedic procedures, especially in elderly patients, due to the deformation of joints. Patients may complain of severe pain due to surgical trauma and prostheses. Regional anaesthesia methods may be performed to reduce the inflammatory response, opioid consumption, and opioid-related side effects.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hip Osteoarthritis Hip Arthropathy Hip Arthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control group

Ultrasound-guided ESPB - 20ml 0,2% ropivacaine + 2ml 0.9% NaCl

Group Type ACTIVE_COMPARATOR

0.9%NaCl

Intervention Type DRUG

20ml 0.2% Ropivacaine + 2.0ml 0.9% NaCl

Dexamethasone

Ultrasound-guided ESPB - 20ml 0,2% ropivacaine + 4mg Dexamethasone

Group Type ACTIVE_COMPARATOR

Dexamethasone 4mg

Intervention Type DRUG

20ml 0.2% Ropivacaine + 4mg Dexamethasone

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

0.9%NaCl

20ml 0.2% Ropivacaine + 2.0ml 0.9% NaCl

Intervention Type DRUG

Dexamethasone 4mg

20ml 0.2% Ropivacaine + 4mg Dexamethasone

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients scheduled for total hip arthroplasty
* patients aged \>65 and \<100 years
* patients able to provide informed consent
* patients able to reliably report symptoms to the research team